DocWire News Editors

DocwireNews

Multiple myeloma (MM) patients with a fracture at diagnosis have a higher risk of dying compared to patients without a fracture, according to a study presented at the 17th International Myeloma Workshop.In this study, researchers assessed patients diagnosed with MM from the Swedish Cancer Register, collating information on date of birth, MM diagnosis, fractures, and death from central registries. They used a Cox regression model to estimate the impact of fractures at diagnosis within 30 days before or after diagnosis. The researchers used a second Cox regression model to evaluate fractures as time-dependent variables. Subsequently, they compared the difference in the link between fracture and survival in two calendar periods &ndash; 1990 to 1999 and 2000 to 2013. Overall, 14,013 patients were diagnosed with MM during the study, of which nearly 9% were diagnosed with a fracture at MM diagnosis, and 23% were diagnosed with a fracture following MM diagnosis.After adjusting for age, sex, time of diagnosis, and previous fractures, the results showed that patients with a fracture at diagnosis were at a significantly higher risk of death (HR=1.28; 95% CI, 1.19 to 1.37). Moreover, the risk of death was notably increased for patients who developed a fracture after the time of MM diagnosis (HR=2.00; 95% CI, 1.90 to 2.10), for all fractures combined.&ldquo;Our large study, including over 14,000 patients diagnosed with MM in Sweden in the years 1990 to 2013, shows that patients with a fracture at diagnosis have a 28% higher risk of dying compared to patients without a fracture,&rdquo; the researchers wrote in their conclusion.They added that MM patients who &ldquo;develop a fracture after the time of MM diagnosis are at twofold risk of dying compared to MM patients that do not develop a fracture, and this risk has not decreased significantly after the introduction of more effective treatment agents in MM. Our results stress the importance of preventing bone disease in MM.&rdquo;Ledergor Thorsteinsdottir, et al. Fractures and Survival in Multiple Myeloma: Results from a Population-Based Study. Presented at the 17th International Myeloma Workshop; September 12-15, 2019; Boston, MA.

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Jordana Jampel

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

Melanoma

Latest News

Fractures and Survival in Multiple Myeloma: Results from a Population-Based Study

International Myeloma Workshop 2019

Multiple myeloma (MM) patients with a fracture at diagnosis have a higher risk of dying compared to patients without a fracture

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe